027510558	027510558	CD	B-NP	O
|	|	NN	I-NP	O
SSMC	SSMC	NN	I-NP	O
|	|	NN	I-NP	O
60508172	60508172	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
8606805	8606805	CD	B-NP	O
|	|	CC	I-NP	O
3/15/2006	3/15/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
NSTEMI	NSTEMI	NNP	I-NP	I-protein
,	,	,	O	O
CHF	CHF	NNP	B-NP	O
|	|	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/27/2006	2/27/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/8/2006	4/8/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
HOLLOWELL	HOLLOWELL	NNP	B-NP	O
,	,	,	O	O
DARRIN	DARRIN	NNP	B-NP	O
279-55-38-8	279-55-38-8	CD	I-NP	O
Co	Co	NNP	I-NP	O
Range	Range	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
1/16/06	1/16/06	CD	B-NP	O
AT	AT	NN	I-NP	O
05	05	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NN	I-NP	O
CONTINGENT	CONTINGENT	NN	I-NP	O
UPON	UPON	NN	I-NP	O
HO	HO	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
WILL	WILL	MD	B-VP	O
D/C	D/C	NNP	B-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
MARBURGER	MARBURGER	NNP	B-NP	O
,	,	,	O	O
EDWARD	EDWARD	NNP	B-NP	O
J.	J.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ENTERIC	ENTERIC	NNP	B-NP	O
COATED	COATED	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
1/5/06	1/5/06	CD	B-NP	O
by	by	IN	B-PP	O
LOUX	LOUX	NNP	B-NP	O
,	,	,	O	O
DOUGLAS	DOUGLAS	NNP	B-NP	O
K.	K.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
110048206	110048206	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
MDA	MDA	NN	B-NP	B-protein
ATENOLOL	ATENOLOL	NN	I-NP	I-protein
50	50	CD	B-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
9/1	9/1	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
PLAVIX	PLAVIX	NN	I-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
CLOPIDOGREL	CLOPIDOGREL	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	O	I-protein
75	75	CD	B-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
Starting	Starting	NNP	I-NP	I-protein
Tomorrow	Tomorrow	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
6/27	6/27	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
LOVENOX	LOVENOX	NN	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
ENOXAPARIN	ENOXAPARIN	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
100	100	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
SC	SC	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
X	X	SYM	B-VP	I-protein
14	14	CD	B-NP	I-protein
doses	dose	NNS	I-NP	I-protein
Starting	Start	VBG	B-VP	I-protein
Today	Today	NN	B-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
6/27	6/27	CD	I-NP	I-protein
-RRB-	-RRB-	SYM	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
INR	INR	NN	B-NP	O
2-3	2-3	CD	B-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
Only	Only	RB	B-ADVP	O
use	use	VBP	B-VP	O
until	until	IN	B-SBAR	O
INR	INR	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
therapeutic	therapeutic	JJ	B-NP	O
2-3	2-3	NN	I-NP	O
ZETIA	ZETIA	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
EZETIMIBE	EZETIMIBE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
FELODIPINE	FELODIPINE	NNP	I-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

FENOFIBRATE	FENOFIBRATE	JJ	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
TRICOR	TRICOR	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
145	145	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
1/5/06	1/5/06	CD	B-NP	O
by	by	IN	B-PP	O
REHKOP	REHKOP	NNP	B-NP	O
,	,	,	O	O
HARRIS	HARRIS	NNP	B-NP	O
L.	L.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
110048206	110048206	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
FENOFIBRATE	FENOFIBRATE	NNP	B-NP	O
,	,	,	I-NP	O
MICRONIZED	MICRONIZED	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
MDA	MDA	NN	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/8/06	10/8/06	CD	B-NP	O
by	by	IN	B-PP	O
AGOSTA	AGOSTA	NNP	B-NP	O
,	,	,	O	O
RIGOBERTO	RIGOBERTO	NNP	B-NP	O
B.	B.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
SIMVASTATIN	SIMVASTATIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
406819453	406819453	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
FENOFIBRATE	FENOFIBRATE	NNP	B-NP	O
,	,	,	I-NP	O
MICRONIZED	MICRONIZED	NNP	I-NP	O
&	&	CC	I-NP	O
SIMVASTATIN	SIMVASTATIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
MDA	MDA	NN	B-NP	O
Number	Number	NN	I-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
20	20	CD	B-NP	O
GLYBURIDE	GLYBURIDE	NN	I-NP	B-protein
2.5	2.5	CD	B-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
DAILY	DAILY	NN	I-NP	I-protein
HYZAAR	HYZAAR	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	O
12.5	12.5	CD	I-NP	O
MG/50	MG/50	NN	I-NP	O
MG	MG	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	NN	I-NP	O
1	1	CD	I-NP	O
...	...	:	O	O
-RRB-	-RRB-	SYM	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	B-protein
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
1/16/06	1/16/06	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LOSARTAN	LOSARTAN	NNP	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LOSARTAN	LOSARTAN	NNP	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
mda	mda	NN	B-NP	B-DNA
SIMVASTATIN	SIMVASTATIN	NN	I-NP	I-DNA
80	80	CD	B-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
BEDTIME	BEDTIME	NNP	I-NP	I-DNA
Food/Drug	Food/Drug	NNP	I-NP	I-DNA
Interaction	Interaction	NNP	I-NP	I-DNA
Instruction	Instruction	NNP	I-NP	I-DNA
Avoid	Avoid	NNP	I-NP	I-DNA
grapefruit	grapefruit	NN	I-NP	I-DNA
unless	unless	IN	B-SBAR	I-DNA
MD	MD	NN	B-NP	I-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Override	Override	NNP	B-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
1/5/06	1/5/06	CD	B-NP	O
by	by	IN	B-PP	O
LIMAS	LIMAS	NNP	B-NP	O
,	,	,	O	O
DARREL	DARREL	NNP	B-NP	O
V.	V.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
110048206	110048206	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
MDA	MDA	NN	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/8/06	10/8/06	CD	B-NP	O
by	by	IN	B-PP	O
NURTHEN	NURTHEN	NNP	B-NP	O
,	,	,	O	O
DOMINGO	DOMINGO	NNP	B-NP	O
R.	R.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
MULTIVITAMIN	MULTIVITAMIN	NN	B-NP	O
THERAPEUTIC	THERAPEUTIC	NN	I-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
472013537	472013537	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
NIACIN	NIACIN	NNP	I-NP	O
,	,	,	O	O
VIT	VIT	NNP	B-NP	O
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
MDA	MDA	NN	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/8/06	10/8/06	CD	B-NP	O
by	by	IN	B-PP	O
STRUVE	STRUVE	NN	B-NP	O
,	,	,	O	O
SANTIAGO	SANTIAGO	NNP	B-NP	O
K.	K.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
FENOFIBRATE	FENOFIBRATE	NNP	B-NP	O
,	,	,	I-NP	O
MICRONIZED	MICRONIZED	NNP	I-NP	O
&	&	CC	I-NP	O
SIMVASTATIN	SIMVASTATIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
MDA	MDA	NN	B-NP	O
COUMADIN	COUMADIN	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
4	4	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
NOW	NOW	NNP	I-NP	O
,	,	,	O	O
Within	Within	NNP	B-NP	O
Hour	Hour	NNP	I-NP	O
of	of	IN	B-PP	O
Pharmacy	Pharmacy	NNP	B-NP	O
Approval	Approval	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
1/5/06	1/5/06	CD	B-NP	O
by	by	IN	B-PP	O
LAFERTY	LAFERTY	NNP	B-NP	O
,	,	,	O	O
SEBASTIAN	SEBASTIAN	NNP	B-NP	O
D.	D.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
FENOFIBRATE	FENOFIBRATE	NNP	B-NP	O
,	,	,	I-NP	O
MICRONIZED	MICRONIZED	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
MDA	MDA	NN	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
Fluid	Fluid	NN	B-NP	O
restriction	restriction	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
2100	2100	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
CARD	CARD	NN	B-NP	O
DR	DR	NN	I-NP	O
STILLSON	STILLSON	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
389	389	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
710-9257	710-9257	CD	I-NP	O
CLINIC	CLINIC	NN	I-NP	O
WILL	WILL	MD	B-VP	O
CONTACT	CONTACT	NN	B-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
CAILLER	CAILLER	NNP	I-NP	O
,	,	,	O	O
CARROLL	CARROLL	NNP	B-NP	O
336-715-9632	336-715-9632	CD	I-NP	O
CLINIC	CLINIC	NN	I-NP	O
WILL	WILL	NN	I-NP	O
CONTACT	CONTACT	NN	I-NP	O
,	,	,	O	O
Coumadin	Coumadin	NN	B-NP	O
clinic	clinic	NN	I-NP	O
2-3	2-3	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
Arrange	Arrange	NNP	B-NP	O
INR	INR	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
8/10/06	8/10/06	CD	B-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
INR	INR	NNP	B-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
7	7	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
's	's	POS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
Coumadin	Coumadin	NNP	B-NP	O
Clinic	Clinic	NNP	I-NP	O
affiliated	affiliate	VBN	B-VP	O
with	with	IN	B-PP	O
PCP	PCP	NN	B-NP	O
ALLERGY	ALLERGY	NN	I-NP	O
:	:	:	O	O
PERCOCET	PERCOCET	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
NSTEMI	NSTEMI	NNP	B-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
NSTEMI	NSTEMI	NNP	I-NP	O
,	,	,	O	O
CHF	CHF	NNP	B-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
chf	chf	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
icmp	icmp	NN	I-NP	O
cad	cad	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
cabg	cabg	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
cardiac	cardiac	JJ	I-NP	O
bypass	bypass	NN	I-NP	O
graft	graft	NN	I-NP	O
surgery	surgery	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
avr	avr	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
cardiac	cardiac	JJ	I-NP	O
valve	valve	NN	I-NP	O
replacement	replacement	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
afib	afib	JJ	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
oa	oa	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
osteoarthritis	osteoarthritis	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
djd	djd	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
degenerative	degenerative	JJ	I-NP	O
joint	joint	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
dm	dm	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
hyperlipidemia	hyperlipidemia	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hyperlipidemia	hyperlipidemia	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
osa	osa	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
gerd	gerd	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
gastroesophageal	gastroesophageal	JJ	I-NP	O
reflux	reflux	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
colon	colon	NN	I-NP	O
polyps	polyp	NNS	I-NP	O
-LRB-	-LRB-	VBP	B-VP	O
colonic	colonic	JJ	B-NP	O
polyps	polyp	NNS	I-NP	O
-RRB-	-RRB-	TO	B-PP	O
tobacco	tobacco	NN	B-NP	O
history	history	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
past	past	JJ	I-NP	O
smoking	smoking	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
Catheterization	Catheterization	NN	B-NP	B-protein
5/8/06	5/8/06	CD	I-NP	I-protein
--	--	:	O	O
restented	restente	VBD	B-VP	O
distal	distal	JJ	B-NP	O
OM2	OM2	NN	I-NP	O
thrombosed	thrombose	VBD	B-VP	O
stent	stent	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
CYPHER	CYPHER	NN	I-NP	O
DES	DES	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
TTE	TTE	NNP	I-NP	O
4/18/06	4/18/06	CD	I-NP	O
:	:	:	O	O
Pending	Pende	VBG	B-VP	O
CXR	CXR	NN	B-NP	O
3/2/06	3/2/06	CD	I-NP	O
:	:	:	O	O
CLINICAL	CLINICAL	JJ	B-NP	O
INDICATION	INDICATION	NN	I-NP	O
:	:	:	O	O
Non-ST	Non-ST	JJ	B-NP	O
elevation	elevation	NN	I-NP	O
MI	MI	NN	I-NP	O
,	,	,	O	O
pulmonary	pulmonary	JJ	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

IMPRESSION	IMPRESSION	NN	B-NP	O
:	:	:	O	O
PA	PA	NN	B-NP	O
and	and	CC	O	O
lateral	lateral	JJ	B-NP	O
examination	examination	NN	I-NP	O
is	be	VBZ	B-VP	O
interpreted	interpret	VBN	I-VP	O
without	without	IN	B-PP	O
comparison	comparison	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
lungs	lung	NNS	I-NP	O
are	be	VBP	B-VP	O
well	well	RB	I-VP	O
expanded	expand	VBN	I-VP	O
and	and	CC	O	O
are	be	VBP	B-VP	O
free	free	JJ	B-ADJP	O
of	of	IN	B-PP	O
consolidations	consolidation	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
lungs	lung	NNS	I-NP	O
are	be	VBP	B-VP	O
well	well	RB	I-VP	O
expanded	expand	VBN	I-VP	O
and	and	CC	O	O
free	free	JJ	B-ADJP	O
of	of	IN	B-PP	O
consolidations	consolidation	NNS	B-NP	O
or	or	CC	I-NP	O
effusions	effusion	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
CABG	CABG	NN	I-NP	O
and	and	CC	O	O
cardiac	cardiac	JJ	B-NP	O
valve	valve	NN	I-NP	O
surgery	surgery	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
moderate	moderate	JJ	B-NP	O
cardiomegaly	cardiomegaly	NN	I-NP	O
.	.	.	O	O

Calcification	Calcification	NN	B-NP	O
is	be	VBZ	B-VP	O
seen	see	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
arch	arch	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
aorta	aorta	NN	I-NP	O
but	but	CC	O	O
the	the	DT	B-NP	O
mediastinum	mediastinum	NN	I-NP	O
appears	appear	VBZ	B-VP	O
otherwise	otherwise	RB	B-ADJP	O
unremarkable	unremarkable	JJ	I-ADJP	O
.	.	.	O	O

BRIEF	BRIEF	NN	B-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
HPI	HPI	NN	B-NP	O
:	:	:	O	O
73	73	CD	B-NP	O
yo	yo	NN	I-NP	O
M	M	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
h/o	h/o	NN	I-NP	O
CAD	CAD	NN	I-NP	O
s/p	s/p	NN	I-NP	O
4	4	CD	B-NP	O
vessel	vessel	NN	I-NP	O
CABG	CABG	NN	I-NP	O
and	and	CC	I-NP	O
AVR	AVR	NN	I-NP	B-protein
for	for	IN	B-PP	O
AS	AS	NN	B-NP	O
in	in	IN	B-PP	O
1991	1991	CD	B-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
LIMA	LIMA	NN	I-NP	B-protein
to	to	TO	B-PP	O
LAD	LAD	NN	B-NP	B-protein
,	,	,	O	O
SVGs	SVG	NNS	B-NP	O
to	to	TO	B-PP	O
RCA	RCA	NN	B-NP	B-protein
,	,	,	O	O
D1	D1	NN	B-NP	B-protein
,	,	,	O	O
OM2	OM2	NN	B-NP	B-protein
-RRB-	-RRB-	NNP	B-NP	O
,	,	,	O	O
Afib	Afib	NNP	B-NP	O
,	,	,	O	O
IMI	IMI	NNP	B-NP	O
,	,	,	O	O
hyperlipids	hyperlipid	NNS	B-NP	O
,	,	,	O	O
+	+	SYM	B-VP	O
tob	tob	NN	B-NP	O
,	,	,	O	O
DM2	DM2	NN	B-NP	B-protein
,	,	,	O	O
+	+	SYM	B-NP	O
Fam	Fam	NN	I-NP	O
hx	hx	NN	I-NP	O
,	,	,	O	O
recent	recent	JJ	B-NP	O
PCI	PCI	NN	I-NP	O
in	in	IN	B-PP	O
6/19	6/19	CD	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
3	3	CD	B-NP	O
stents	stent	NNS	I-NP	O
-LRB-	-LRB-	JJ	B-NP	O
2	2	CD	I-NP	O
CYPHERs	CYPHER	NNS	I-NP	O
to	to	TO	B-PP	O
SVG/OM2	SVG/OM2	NN	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
BMS	BMS	NN	I-NP	O
to	to	TO	B-PP	O
OM2	OM2	NN	B-NP	B-protein
distal	distal	JJ	B-ADJP	O
to	to	TO	B-PP	O
insertion	insertion	NN	B-NP	O
point	point	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
now	now	RB	B-ADVP	O
p/w	p/w	NN	B-NP	O
2	2	CD	B-NP	O
weeks	week	NNS	I-NP	O
increasing	increase	VBG	B-VP	O
DOE	DOE	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
acute	acute	JJ	B-NP	O
SOB	SOB	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
minimal	minimal	JJ	I-NP	O
exertion	exertion	NN	I-NP	O
on	on	IN	B-PP	O
3/1	3/1	CD	B-NP	O
No	No	DT	B-NP	O
CP	CP	NN	I-NP	B-DNA
,	,	,	O	O
no	no	DT	B-NP	O
orthopnea	orthopnea	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
PND	PND	NN	I-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
edema	edema	NN	I-NP	O
or	or	CC	I-NP	O
abd	abd	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
palpitations	palpitation	NNS	I-NP	O
,	,	,	O	O
dizziness	dizziness	NN	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
has	have	VBZ	B-VP	O
never	never	RB	I-VP	O
experienced	experience	VBN	I-VP	O
classical	classical	JJ	B-NP	O
angina	angina	NN	I-NP	O
.	.	.	O	O

Presented	Present	VBN	B-VP	O
to	to	TO	B-PP	O
SMC	SMC	NN	B-NP	B-protein
,	,	,	O	O
+	+	JJ	B-NP	O
EKG	EKG	NN	I-NP	O
changes	change	NNS	I-NP	O
,	,	,	O	O
+	+	SYM	B-NP	O
BNP	BNP	NN	I-NP	B-protein
,	,	,	O	O
+	+	SYM	B-NP	O
TNI	TNI	NN	I-NP	B-protein
,	,	,	O	O
started	start	VBN	B-VP	O
on	on	IN	B-PP	O
Integrilin/Heparin	Integrilin/Heparin	NN	B-NP	O
gtt	gtt	NN	I-NP	O
************	************	SYM	B-NP	O
Exam	Exam	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
:	:	:	O	O
T	T	NN	B-NP	O
97.1	97.1	CD	I-NP	O
,	,	,	I-NP	O
94	94	CD	I-NP	O
,	,	,	I-NP	O
130/80	130/80	CD	I-NP	O
,	,	,	I-NP	O
20	20	CD	I-NP	O
,	,	,	I-NP	O
97	97	CD	I-NP	O
%	%	NN	I-NP	O
2L	2L	NN	I-NP	O
NAD	NAD	NN	I-NP	O
,	,	,	O	O
EOMI	EOMI	NN	B-NP	B-protein
,	,	,	O	O
PERL	PERL	NN	B-NP	B-protein
,	,	,	O	O
injected	inject	VBN	B-NP	O
sclera	sclera	NN	I-NP	B-protein
bilat	bilat	NN	I-NP	I-protein
JVP	JVP	NN	I-NP	I-protein
~	~	NN	I-NP	I-protein
12	12	CD	I-NP	I-protein
cm	cm	NN	I-NP	I-protein
CTAB	CTAB	NN	I-NP	I-protein
,	,	,	O	O
no	no	DT	B-NP	O
wheezes	wheeze	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
crackles	crackle	NNS	I-NP	O
Irregular	Irregular	JJ	B-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
nl	nl	NN	B-NP	B-protein
s1/s2	s1/s2	NN	I-NP	I-protein
,	,	,	O	O
+1	+1	CD	B-NP	O
-2	-2	CD	I-NP	O
/	/	SYM	B-NP	O
6	6	CD	I-NP	O
LUSB	LUSB	NN	I-NP	O
metallic	metallic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
no	no	DT	B-NP	O
radiation	radiation	NN	I-NP	O
,	,	,	O	O
+	+	SYM	B-NP	O
LV	LV	NN	I-NP	O
thrill	thrill	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
RV	RV	NN	I-NP	O
heave	heave	NN	I-NP	O
.	.	.	O	O

S/NT/ND	S/NT/ND	NNP	B-NP	O
Ext	Ext	NNP	I-NP	O
WWP	WWP	NNP	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
C/C/E	C/C/E	NN	I-NP	B-protein
Neuro	Neuro	NN	I-NP	I-protein
A	A	NN	I-NP	I-protein
and	and	CC	I-NP	O
O	O	NN	I-NP	B-protein
X	X	NN	I-NP	I-protein
3	3	CD	I-NP	I-protein
,	,	,	O	O
CN	CN	NN	B-NP	O
2-12	2-12	CD	I-NP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

*************	*************	SYM	B-NP	B-protein
LABS	LABS	NN	I-NP	I-protein
:	:	:	O	O
TNI	TNI	NN	B-NP	O
peak	peak	NN	I-NP	O
15	15	CD	I-NP	O
--	--	:	O	O
>	>	SYM	O	O
12	12	CD	B-NP	O
--	--	:	O	O
>	>	SYM	B-NP	O
5	5	CD	B-NP	O
5	5	CD	I-NP	O
CKMB	CKMB	NN	I-NP	O
peak	peak	NN	I-NP	O
28	28	CD	I-NP	O
--	--	:	O	O
>	>	SYM	B-NP	O
3	3	CD	B-NP	O
5	5	CD	I-NP	O
BNP	BNP	NN	I-NP	O
669	669	CD	I-NP	O
--	--	:	O	O
>	>	SYM	B-NP	O
250	250	CD	B-NP	O
274	274	CD	I-NP	O
Cr	Cr	NNP	B-NP	O
0.9	0.9	CD	I-NP	O
,	,	,	O	O
Hct	Hct	NN	B-NP	B-protein
47	47	CD	I-NP	I-protein
,	,	,	O	O
WBC	WBC	NNP	B-NP	O
13	13	CD	I-NP	O
,	,	,	O	O
UA	UA	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
3	3	CD	I-NP	O
+	+	SYM	I-NP	O
RBC	RBC	NN	I-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
WBC	WBC	NNP	I-NP	O
EKG	EKG	NNP	I-NP	O
:	:	:	O	O
new	new	JJ	B-NP	O
TWI	TWI	NN	I-NP	O
,	,	,	O	O
ST	ST	NN	B-NP	O
depressions	depression	NNS	I-NP	O
anterolat	anterolat	NN	I-NP	O
leads	lead	VBZ	B-VP	O
.	.	.	O	O

************	************	SYM	B-NP	O
PROCEDURES/TESTS	PROCEDURES/TESTS	NN	I-NP	O
:	:	:	O	O
EMC	EMC	NN	B-NP	O
10/1/06	10/1/06	CD	I-NP	O
CXR	CXR	NN	I-NP	B-protein
:	:	:	O	O
?	?	.	O	O

PNA	PNA	NN	B-NP	O
,	,	,	O	O
?	?	.	O	O

Effusion	Effusion	NN	B-NP	O
CXR	CXR	NN	I-NP	O
3/2/06	3/2/06	CD	I-NP	O
:	:	:	O	O
no	no	DT	B-NP	O
infiltrate	infiltrate	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
effusions	effusion	NNS	I-NP	O
.	.	.	O	O

+	+	SYM	B-NP	O
cardiomegaly	cardiomegaly	NN	I-NP	O
.	.	.	O	O

MIBI	MIBI	NNP	B-NP	O
8/29/06	8/29/06	CD	I-NP	O
:	:	:	O	O
SH	SH	NN	B-NP	O
:	:	:	O	O
akinetic	akinetic	JJ	B-NP	O
septum	septum	NN	I-NP	O
,	,	,	O	O
HK	HK	NN	B-NP	O
inf/apex	inf/apex	NN	I-NP	O
,	,	,	O	O
lat/inf	lat/inf	JJ	B-NP	O
wall	wall	NN	I-NP	O
reversible	reversible	JJ	I-NP	O
defect	defect	NN	I-NP	O
.	.	.	O	O

31	31	CD	B-NP	O
%	%	NN	I-NP	O
EF	EF	NN	I-NP	O
Cath	Cath	NN	I-NP	O
:	:	:	O	O
CYPHER	CYPHER	NN	B-NP	O
DES	DES	NNP	I-NP	O
to	to	TO	B-PP	O
native	native	JJ	B-NP	O
OM2	OM2	NN	I-NP	O
2.5	2.5	CD	I-NP	O
X13mm	X13mm	NN	I-NP	O
.	.	.	O	O

************	************	SYM	B-NP	O
CONSULTS	CONSULTS	NNS	I-NP	O
:	:	:	O	O
None	None	NN	B-NP	O
************	************	SYM	B-NP	O
PROBLEMS	PROBLEMS	NN	I-NP	O
BY	BY	NN	I-NP	O
SYSTEM	SYSTEM	NN	I-NP	O
:	:	:	O	O
73	73	CD	B-NP	O
yo	yo	NN	I-NP	O
M	M	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
NSTEMI	NSTEMI	NN	B-NP	O
,	,	,	O	O
h/o	h/o	NN	B-NP	O
3VD	3VD	NN	I-NP	O
s/p	s/p	NN	I-NP	O
CABG	CABG	NN	I-NP	O
,	,	,	O	O
transferred	transfer	VBN	B-VP	O
here	here	RB	B-ADVP	O
for	for	IN	B-PP	O
re-cath	re-cath	NN	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	B-protein
w	w	NN	I-NP	I-protein
/	/	SYM	B-NP	O
recent	recent	JJ	I-NP	O
PCI	PCI	NN	I-NP	O
6/19	6/19	CD	I-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
instent	instent	JJ	B-NP	O
thrombosis	thrombosis	NN	I-NP	O
of	of	IN	B-PP	O
OM2	OM2	NN	B-NP	B-protein
.	.	.	O	O

Also	Also	RB	B-ADVP	O
had	have	VBD	B-VP	O
CHF	CHF	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
,	,	,	O	O
Afib	Afib	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
RVR	RVR	NN	I-NP	B-protein
at	at	IN	B-PP	O
EH	EH	NN	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	B-protein
w	w	NN	I-NP	I-protein
/	/	SYM	B-VP	O
no	no	DT	B-NP	O
h/o	h/o	NN	I-NP	O
CP	CP	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
cardiac	cardiac	JJ	I-NP	O
events	event	NNS	I-NP	O
,	,	,	O	O
only	only	RB	B-NP	O
SOB	SOB	NN	I-NP	B-protein
.	.	.	O	O

So	So	RB	B-ADVP	O
any	any	DT	B-NP	O
new	new	JJ	I-NP	O
SOB	SOB	NN	I-NP	B-protein
should	should	MD	B-VP	O
be	be	VB	I-VP	O
considered	consider	VBN	I-VP	O
angina	angina	NN	B-NP	O
equivalent	equivalent	NN	I-NP	O
.	.	.	O	O

--	--	:	O	O
CV	CV	NN	B-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

-LSB-	-LSB-	SYM	O	O
I	I	PRP	B-NP	O
-RSB-	-RSB-	VBP	B-VP	O
--	--	:	O	B-protein
NSTEMI	NSTEMI	NN	B-NP	I-protein
w	w	NN	I-NP	I-protein
/	/	SYM	B-VP	I-protein
enzymes	enzyme	NNS	B-NP	I-protein
trending	trend	VBG	B-VP	O
downward	downward	RB	B-ADVP	O
.	.	.	O	O

Cont	Cont	NNP	B-NP	O
'd	'd	MD	B-VP	O
ASA	ASA	NNP	B-NP	O
325	325	CD	I-NP	O
,	,	,	O	O
Zetia	Zetia	NNP	B-NP	O
,	,	,	O	O
Fenofibrate	Fenofibrate	NNP	B-NP	O
.	.	.	O	O

Changed	Change	VBN	B-NP	O
ARB	ARB	NN	I-NP	B-protein
to	to	TO	B-PP	O
Captopril	Captopril	NNP	B-NP	O
and	and	CC	O	O
titrated	titrate	VBD	B-VP	O
up	up	RB	B-NP	O
to	to	TO	I-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
tid	tid	NN	I-NP	O
.	.	.	O	O

Will	Will	MD	O	O
DC	DC	NNS	B-NP	B-cell_type
on	on	IN	B-PP	O
PO	PO	NN	B-NP	O
lisinopril	lisinopril	NN	I-NP	O
.	.	.	O	O

Titrated	Titrated	NNP	B-NP	O
BB	BB	NNP	I-NP	O
up	up	IN	B-PP	O
to	to	TO	B-PP	O
metoprolol	metoprolol	NN	B-NP	O
50	50	CD	I-NP	O
qid	qid	NN	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
switched	switch	VBD	B-VP	O
to	to	TO	B-PP	O
Toprol	Toprol	NNP	B-NP	O
200	200	CD	I-NP	O
qd	qd	NN	I-NP	O
.	.	.	O	O

Cath	Cath	NN	B-NP	O
on	on	IN	B-PP	O
4/29	4/29	CD	B-NP	O
showing	show	VBG	B-VP	O
instent	instent	JJ	B-NP	O
thrombosis	thrombosis	NN	I-NP	O
likely	likely	RB	B-NP	O
2/2	2/2	CD	I-NP	O
discontinuing	discontinuing	NN	I-NP	O
of	of	IN	B-PP	O
Plavix	Plavix	NNP	B-NP	O
.	.	.	O	O

Stent	Stent	NN	B-NP	O
was	be	VBD	B-VP	O
restented	restente	VBN	I-VP	O
w	w	NN	B-NP	O
/	/	SYM	B-NP	O
CYPHER	CYPHER	NN	I-NP	O
DES	DES	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
pt	pt	NN	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Integrilin	Integrilin	NNP	B-NP	O
gtt	gtt	NN	I-NP	O
as	as	IN	B-PP	O
18	18	CD	B-NP	O
hours	hour	NNS	I-NP	O
,	,	,	O	O
Heparin	Heparin	NN	B-NP	O
stopped	stop	VBD	B-VP	O
.	.	.	O	O

On	On	IN	B-PP	O
Plavix	Plavix	NNP	B-NP	O
now	now	RB	B-ADVP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
should	should	MD	B-VP	O
remain	remain	VB	I-VP	O
on	on	IN	B-PP	O
Plavix	Plavix	NNP	B-NP	O
for	for	IN	B-PP	O
likely	likely	JJ	B-NP	O
>	>	SYM	I-NP	O
3	3	CD	I-NP	O
months	month	NNS	I-NP	O
given	give	VBN	B-VP	O
h/o	h/o	NN	B-NP	O
instent	instent	JJ	I-NP	O
thrombosis	thrombosis	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
time	time	NN	I-NP	O
should	should	MD	B-VP	O
also	also	RB	I-VP	O
be	be	VB	I-VP	O
careful	careful	JJ	B-ADJP	O
for	for	IN	B-PP	O
bleeding	bleed	VBG	B-VP	O
given	give	VBN	B-PP	O
on	on	IN	B-PP	O
ASA/Coumadin/Plavix	ASA/Coumadin/Plavix	NNP	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

-LSB-	-LSB-	NN	B-NP	B-protein
P	P	NN	I-NP	I-protein
-RSB-	-RSB-	NN	I-NP	I-protein
--	--	:	O	O
Last	Last	JJ	B-NP	O
EF	EF	NN	I-NP	O
31	31	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Diuresed	Diurese	VBN	B-VP	O
>	>	JJR	B-NP	O
2L	2L	NN	I-NP	O
at	at	IN	B-PP	O
TVH	TVH	NN	B-NP	B-protein
.	.	.	O	O

Cont	Cont	NNP	B-NP	O
'd	'd	MD	O	O
Lasix	Lasix	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
no	no	DT	B-NP	O
gtt	gtt	NN	I-NP	B-protein
-RRB-	-RRB-	HYPH	O	I-protein
40	40	CD	B-NP	I-protein
mg	mg	NN	I-NP	I-protein
IV	IV	CD	B-NP	I-protein
then	then	RB	I-NP	O
PO	PO	NN	I-NP	O
bid	bid	NN	I-NP	O
and	and	CC	I-NP	O
pt	pt	NN	I-NP	O
diuresed	diurese	VBN	B-VP	O
well	well	RB	B-ADVP	O
at	at	IN	B-PP	O
DAH	DAH	NN	B-NP	O
.	.	.	O	O

Repeat	Repeat	NNP	B-NP	O
Echo	Echo	NNP	I-NP	O
4/18/06	4/18/06	CD	I-NP	O
pending	pende	VBG	I-NP	O
results	result	NNS	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
's	's	POS	B-NP	O
exam	exam	NN	I-NP	O
,	,	,	O	O
CXR	CXR	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
sxs	sx	NNS	B-NP	O
all	all	DT	O	O
resolved	resolve	VBN	B-VP	O
throughout	throughout	IN	B-PP	O
hospital	hospital	NN	B-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

May	May	MD	O	O
need	need	VBP	B-VP	O
aldosterone	aldosterone	NN	B-NP	O
antagonist	antagonist	NN	I-NP	O
given	give	VBN	B-VP	O
failure	failure	NN	B-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

-LSB-	-LSB-	JJ	B-NP	B-protein
R	R	NN	I-NP	I-protein
-RSB-	-RSB-	NN	I-NP	I-protein
--	--	:	O	O
Afib	Afib	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
no	no	DT	B-NP	O
RVR	RVR	NN	I-NP	B-protein
.	.	.	O	O

Cont	Cont	NNP	B-NP	O
Tele	Tele	NNP	I-NP	O
.	.	.	O	O

Has	Has	NNP	B-NP	O
had	have	VBD	B-VP	O
some	some	DT	B-NP	O
pauses	pause	NNS	I-NP	O
up	up	IN	B-NP	O
to	to	TO	I-NP	O
4	4	CD	I-NP	O
seconds	second	NNS	I-NP	O
-LRB-	-LRB-	IN	B-PP	O
these	these	DT	B-NP	O
have	have	VBP	B-VP	O
not	not	RB	I-VP	O
been	be	VBN	I-VP	O
new	new	JJ	B-ADJP	O
--	--	:	O	O
were	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
years	year	NNS	B-NP	O
ago	ago	RB	B-ADVP	O
on	on	IN	B-PP	O
holter	holter	NN	B-NP	B-protein
monitor	monitor	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

May	May	MD	O	O
need	need	VBP	B-VP	O
AICD	AICD	NN	B-NP	O
+	+	SYM	B-VP	O
/	/	SYM	B-NP	O
-	-	HYPH	B-NP	O
biventricular	biventricular	JJ	I-NP	O
PPM	PPM	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
done	do	VBN	I-VP	O
as	as	IN	B-PP	O
outpt	outpt	NN	B-NP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Howard	Howard	NNP	I-NP	O
Geddes	Geddes	NNP	I-NP	O
Will	Will	NNP	I-NP	O
also	also	RB	B-ADVP	O
get	get	VBP	B-VP	O
re-eval	re-eval	JJ	B-ADJP	O
of	of	IN	B-PP	O
LV	LV	NN	B-NP	B-protein
fxn	fxn	NN	I-NP	I-protein
in	in	IN	B-PP	O
6-8	6-8	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

--	--	:	O	O
PULM	PULM	NN	B-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	B-protein
w	w	NN	I-NP	I-protein
/	/	SYM	B-NP	O
severe	severe	JJ	I-NP	O
OSA	OSA	NN	I-NP	O
.	.	.	O	O

Has	Ha	NNS	B-NP	B-protein
n't	n't	RB	O	O
started	start	VBN	B-VP	O
CPAP	CPAP	NN	B-NP	B-protein
as	as	IN	B-PP	O
outpt	outpt	NN	B-NP	O
.	.	.	O	O

Started	Started	JJ	B-NP	B-protein
CPAP	CPAP	NN	I-NP	I-protein
as	as	IN	B-PP	O
inpt	inpt	NN	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
tolerated	tolerate	VBD	B-VP	O
this	this	DT	B-NP	O
well	well	RB	I-NP	O
.	.	.	O	O

Needs	Need	NNS	B-NP	O
to	to	TO	B-VP	O
f/u	f/u	VB	I-VP	O
w	w	NN	B-NP	O
/	/	SYM	B-NP	O
PCP	PCP	NN	I-NP	O
to	to	TO	B-VP	O
get	get	VB	I-VP	O
CPAP	CPAP	NN	B-NP	B-protein
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

--	--	:	O	O
GI	GI	NN	B-NP	O
:	:	:	O	O
ADA/low	ADA/low	NNP	B-NP	O
Na/low	Na/low	NNP	I-NP	O
Chol	Chol	NN	I-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

Replete	Replete	JJ	B-NP	O
lytes	lyte	NNS	I-NP	O
.	.	.	O	O

Mg/Kcl	Mg/Kcl	NN	B-NP	O
SS	SS	NN	I-NP	O
.	.	.	O	O

LFTs	LFT	NNS	B-NP	O
were	be	VBD	B-VP	O
resolving	resolve	VBG	I-VP	O
.	.	.	O	O

Likely	Likely	RB	B-ADVP	O
elevated	elevate	VBD	B-VP	O
2/2	2/2	CD	B-NP	O
hepatic	hepatic	JJ	I-NP	O
congestion	congestion	NN	I-NP	O
.	.	.	O	O

--	--	:	O	O
RENAL	RENAL	NN	B-NP	O
:	:	:	O	O
baseline	baseline	NN	B-NP	O
Cr	Cr	NN	I-NP	O
1.3	1.3	CD	I-NP	O
.	.	.	O	O

given	give	VBN	B-NP	O
Mucomyst/Bicarb	Mucomyst/Bicarb	NN	I-NP	O
pericath	pericath	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
h/o	h/o	NN	I-NP	O
CRI	CRI	NN	I-NP	O
.	.	.	O	O

--	--	:	O	O
ENDO	ENDO	NN	B-NP	O
:	:	:	O	O
Held	Held	JJ	B-NP	O
home	home	NN	I-NP	O
DM	DM	NN	I-NP	O
meds	med	NNS	I-NP	O
,	,	,	O	O
A1C	A1C	NN	B-NP	B-protein
--	--	:	O	O
>	>	SYM	B-NP	O
6.4	6.4	CD	I-NP	O
,	,	,	O	O
started	start	VBN	B-VP	O
on	on	IN	B-PP	O
basal/prandial/SS	basal/prandial/SS	NN	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
to	to	TO	B-VP	O
keep	keep	VB	I-VP	O
BS	BS	NNP	B-NP	O
<	<	SYM	B-NP	O
110	110	CD	I-NP	O
.	.	.	O	O

--	--	:	O	B-protein
NEURO/PAIN	NEURO/PAIN	NN	B-NP	I-protein
:	:	:	O	O
No	No	DT	B-NP	O
issues	issue	NNS	I-NP	O
.	.	.	O	O

--	--	:	O	O
PROPHY	PROPHY	NN	B-NP	O
:	:	:	O	O
Lovenox	Lovenox	NN	B-NP	O
bridge	bridge	NN	I-NP	O
to	to	TO	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
.	.	.	O	O

--	--	:	O	O
CODE	CODE	NN	B-NP	O
:	:	:	O	O
FULL	FULL	NN	B-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Dear	Dear	NNP	B-NP	O
Mr.	Mr.	NNP	I-NP	O
Rumpf	Rumpf	NNP	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
pleasure	pleasure	NN	I-NP	O
taking	take	VBG	B-VP	O
care	care	NN	B-NP	O
of	of	IN	B-PP	O
you	you	PRP	B-NP	O
while	while	IN	B-SBAR	O
you	you	PRP	B-NP	O
were	be	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
you	you	PRP	B-NP	O
know	know	VBP	B-VP	O
,	,	,	O	O
you	you	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
heart	heart	NN	I-NP	O
attack	attack	NN	I-NP	O
because	because	IN	B-SBAR	O
your	your	PRP$	B-NP	O
previous	previous	JJ	I-NP	O
stent	stent	NN	I-NP	O
was	be	VBD	B-VP	O
occluded	occlude	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
interventional	interventional	JJ	I-NP	O
cardiologist	cardiologist	NN	I-NP	O
restented	restente	VBD	B-VP	O
this	this	DT	B-NP	O
vessel	vessel	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
catheterization	catheterization	NN	I-NP	B-protein
lab	lab	NN	I-NP	I-protein
.	.	.	O	O

Please	Please	NN	B-NP	B-protein
,	,	,	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
crucial	crucial	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
you	you	PRP	B-NP	O
continue	continue	VBP	B-VP	O
taking	take	VBG	I-VP	O
your	your	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
as	as	IN	B-SBAR	O
instructed	instruct	VBN	B-VP	O
,	,	,	O	O
especially	especially	RB	B-NP	O
ASPIRIN	ASPIRIN	NN	I-NP	O
and	and	CC	I-NP	O
PLAVIX	PLAVIX	NN	I-NP	B-protein
.	.	.	O	O

Please	Please	VB	B-VP	O
take	take	VB	I-VP	O
these	these	DT	B-NP	O
medications	medication	NNS	I-NP	O
every	every	DT	B-NP	O
day	day	NN	I-NP	O
until	until	IN	B-SBAR	O
instructed	instruct	VBN	B-VP	O
otherwise	otherwise	RB	B-ADVP	O
by	by	IN	B-PP	O
your	your	PRP$	B-NP	O
doctors	doctor	NNS	I-NP	O
.	.	.	O	O

Please	Please	NN	B-NP	B-protein
weigh	weigh	VBP	B-VP	O
yourself	yourself	PRP	B-NP	O
daily	daily	RB	B-ADVP	O
and	and	CC	O	O
keep	keep	VB	B-VP	O
records	record	NNS	B-NP	O
of	of	IN	B-PP	O
your	your	PRP$	B-NP	O
weight	weight	NN	I-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
you	you	PRP	B-NP	O
experience	experience	VBP	B-VP	O
worsening	worsen	VBG	I-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
with	with	IN	B-PP	O
exertion	exertion	NN	B-NP	O
or	or	CC	B-PP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
,	,	,	O	O
have	have	VBP	B-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
dizziness	dizziness	NN	B-NP	O
,	,	,	O	O
fainting	fainting	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
swelling	swelling	NN	B-NP	O
,	,	,	O	O
please	please	VB	B-INTJ	O
call	call	VB	B-VP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
right	right	RB	B-ADVP	O
away	away	RB	I-ADVP	O
or	or	CC	O	O
go	go	VB	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

Titrate	Titrate	NN	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
to	to	TO	B-PP	O
goal	goal	NN	B-NP	O
INR	INR	NN	I-NP	O
2-3	2-3	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

Pt	Pt	NN	B-NP	O
likely	likely	RB	B-VP	O
needs	need	VBZ	I-VP	O
CPAP	CPAP	NN	B-NP	B-protein
machine	machine	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
failed	fail	VBD	B-VP	O
sleep	sleep	JJ	B-NP	O
study	study	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

Titrate	Titrate	NNP	B-NP	O
ACEi	ACEi	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
was	be	VBD	B-VP	O
previously	previously	RB	B-ADVP	O
on	on	IN	B-PP	O
ARB	ARB	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-VP	O
,	,	,	O	O
BB	BB	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
now	now	RB	B-ADVP	O
on	on	IN	B-PP	O
Toprol	Toprol	NNP	B-NP	O
XL	XL	NNP	I-NP	O
200	200	CD	I-NP	O
,	,	,	O	O
instead	instead	RB	B-PP	O
of	of	IN	I-PP	O
atenolol	atenolol	NN	B-NP	B-protein
25	25	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
4	4	CD	B-NP	I-protein
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

Likely	Likely	RB	B-ADVP	O
needs	need	VBZ	B-VP	O
re-eval	re-eval	NN	B-NP	O
of	of	IN	B-PP	O
LV	LV	NN	B-NP	B-protein
fxn	fxn	NN	I-NP	I-protein
in	in	IN	B-PP	O
6-8	6-8	CD	B-NP	O
meeks	meek	NNS	I-NP	O
,	,	,	O	O
AICD/PPM	AICD/PPM	NN	B-NP	O
,	,	,	O	O
consider	consider	VB	B-VP	O
aldosterone	aldosterone	NN	B-NP	O
antagonist	antagonist	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
PORTILLO	PORTILLO	NNP	B-NP	O
,	,	,	O	O
CARROL	CARROL	NNP	B-NP	O
J.	J.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DX313	DX313	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
1/16/06	1/16/06	CD	I-NP	O
@	@	SYM	B-NP	O
02	02	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

